| scholarly article | Q13442814 |
| P2093 | author name string | Thompson CB | |
| Arch RH | |||
| P2860 | cites work | The human OX40 homolog: cDNA structure, expression and chromosomal assignment of the ACT35 antigen | Q24305105 |
| A novel RING finger protein interacts with the cytoplasmic domain of CD40 | Q24306382 | ||
| Involvement of CRAF1, a relative of TRAF, in CD40 signaling | Q24306746 | ||
| I-TRAF is a novel TRAF-interacting protein that regulates TRAF-mediated signal transduction | Q24313173 | ||
| ILA, a member of the human nerve growth factor/tumor necrosis factor receptor family, regulates T-lymphocyte proliferation and survival | Q24313254 | ||
| Presence of a new conserved domain in CART1, a novel member of the tumor necrosis factor receptor-associated protein family, which is expressed in breast carcinoma | Q24315735 | ||
| Cross-linking of OX40 ligand, a member of the TNF/NGF cytokine family, induces proliferation and differentiation in murine splenic B cells | Q24317763 | ||
| A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor | Q24318280 | ||
| Identification of a human OX-40 ligand, a costimulator of CD4+ T cells with homology to tumor necrosis factor | Q24319938 | ||
| Molecular and biological characterization of human 4-1BB and its ligand | Q24320045 | ||
| A receptor induced by lymphocyte activation (ILA): a new member of the human nerve-growth-factor/tumor-necrosis-factor receptor family | Q24322784 | ||
| cDNA sequences of two inducible T-cell genes | Q24621040 | ||
| TRAF5, a novel tumor necrosis factor receptor-associated factor family protein, mediates CD40 signaling | Q24634187 | ||
| Retracted: Tumor necrosis factor receptor-associated factor (TRAF)-1, TRAF-2, and TRAF-3 interact in vivo with the CD30 cytoplasmic domain; TRAF-2 mediates CD30-induced nuclear factor kappa B activation | Q24679579 | ||
| Basic local alignment search tool | Q25938991 | ||
| The retinoblastoma protein associates with the protein phosphatase type 1 catalytic subunit | Q27860669 | ||
| Gene structure and chromosomal localization of the mouse homologue of rat OX40 protein | Q28118387 | ||
| CD30 contains two binding sites with different specificities for members of the tumor necrosis factor receptor-associated factor family of signal transducing proteins | Q28281794 | ||
| TRAF5, an activator of NF-kappaB and putative signal transducer for the lymphotoxin-beta receptor | Q28282051 | ||
| Tumor necrosis factor receptor-associated factor (TRAF) 5 and TRAF2 are involved in CD30-mediated NFkappaB activation | Q28301504 | ||
| Identification of TRAF6, a novel tumor necrosis factor receptor-associated factor protein that mediates signaling from an amino-terminal domain of the CD40 cytoplasmic region | Q28511583 | ||
| Characterization of the MRC OX40 antigen of activated CD4 positive T lymphocytes--a molecule related to nerve growth factor receptor | Q28576279 | ||
| TRAF2-mediated activation of NF-kappa B by TNF receptor 2 and CD40 | Q28610812 | ||
| Role of 4-1BB ligand in costimulation of T lymphocyte growth and its upregulation on M12 B lymphomas by cAMP. | Q36364613 | ||
| The T cell-B cell interaction via OX40-OX40L is necessary for the T cell-dependent humoral immune response | Q36365985 | ||
| The human OX40/gp34 system directly mediates adhesion of activated T cells to vascular endothelial cells | Q36366597 | ||
| Induction of nuclear factor kappaB by the CD30 receptor is mediated by TRAF1 and TRAF2. | Q36566021 | ||
| Tumor necrosis factor ligand superfamily: involvement in the pathology of malignant lymphomas. | Q40544191 | ||
| Tumor necrosis factor receptor superfamily members and their ligands | Q40626257 | ||
| Expression of the human OX40 (hOX40) antigen in normal and neoplastic tissues | Q41265266 | ||
| The v-abl tyrosine kinase negatively regulates NF-kappa B/Rel factors and blocks kappa gene transcription in pre-B lymphocytes | Q41481010 | ||
| 75 Assay of transforming activity of tumor virus DNA | Q45803657 | ||
| TANK, a co-inducer with TRAF2 of TNF- and CD 40L-mediated NF-kappaB activation | Q48064873 | ||
| Genomic organization and chromosomal localization of the T-cell antigen 4-1BB. | Q48084408 | ||
| 4-1BB is expressed on CD45RAhiROhi transitional T cell in humans. | Q52048535 | ||
| Signals through 4-1BB are costimulatory to previously activated splenic T cells and inhibit activation-induced cell death | Q56908523 | ||
| Potential role of 4-1BB in T cell activation. Comparison with the costimulatory molecule CD28 | Q56909347 | ||
| Expression characteristics of two potential T cell mediator genes | Q69208261 | ||
| Selective depletion of myelin-reactive T cells with the anti-OX-40 antibody ameliorates autoimmune encephalomyelitis | Q70934403 | ||
| OX40 is differentially expressed on activated rat and mouse T cells and is the sole receptor for the OX40 ligand | Q71420856 | ||
| OX-40 antibody enhances for autoantigen specific V beta 8.2+ T cells within the spinal cord of Lewis rats with autoimmune encephalomyelitis | Q71609053 | ||
| Costimulation of CD28- T lymphocytes by 4-1BB ligand | Q71968269 | ||
| Putative cytoplasmic amphiphilic domains in the nerve growth factor/tumour necrosis factor receptor superfamily | Q72872873 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Tumor necrosis factor receptor superfamily, member 4 | Q14907610 |
| TNF receptor-associated factor 2 | Q14914363 | ||
| TNF | Q18032037 | ||
| P304 | page(s) | 558-565 | |
| P577 | publication date | 1998-01-01 | |
| P1433 | published in | Molecular and Cellular Biology | Q3319478 |
| P1476 | title | 4-1BB and Ox40 are members of a tumor necrosis factor (TNF)-nerve growth factor receptor subfamily that bind TNF receptor-associated factors and activate nuclear factor kappaB | |
| P478 | volume | 18 |
| Q64053615 | 2B4 costimulatory domain enhancing cytotoxic ability of anti-CD5 chimeric antigen receptor engineered natural killer cells against T cell malignancies |
| Q28217502 | 4-1BB (CD137) controls the clonal expansion and survival of CD8 T cells in vivo but does not contribute to the development of cytotoxicity |
| Q59134955 | 4-1BB enhancement of CAR T function requires NF-κB and TRAFs |
| Q24291798 | A DAP12-mediated pathway regulates expression of CC chemokine receptor 7 and maturation of human dendritic cells |
| Q92215112 | A mathematical model of combined CD8 T cell costimulation by 4-1BB (CD137) and OX40 (CD134) receptors |
| Q54768658 | A recombinant vector expressing transgenes for four T-cell costimulatory molecules (OX40L, B7-1, ICAM-1, LFA-3) induces sustained CD4+ and CD8+ T-cell activation, protection from apoptosis, and enhanced cytokine production. |
| Q36254865 | Activation of NF-kappaB by HTLV-I and implications for cell transformation |
| Q28138697 | Activation of NF-kappaB by RANK requires tumor necrosis factor receptor-associated factor (TRAF) 6 and NF-kappaB-inducing kinase. Identification of a novel TRAF6 interaction motif |
| Q36696891 | Activation of NF-kappaB1 by OX40 contributes to antigen-driven T cell expansion and survival |
| Q34358363 | Activation of OX40 Augments Th17 Cytokine Expression and Antigen-Specific Uveitis |
| Q35427446 | Agonist antibodies to TNFR molecules that costimulate T and NK cells |
| Q34577189 | Altered T cell responses in children with autism |
| Q84675386 | Altered expression of TNFSF4 and TRAF2 mRNAs in peripheral blood mononuclear cells in patients with systemic lupus erythematosus: association with atherosclerotic symptoms and lupus nephritis |
| Q35717963 | An alternative signal 3: CD8⁺ T cell memory independent of IL-12 and type I IFN is dependent on CD27/OX40 signaling |
| Q40746656 | Anoxia-induced apoptosis occurs through a mitochondria-dependent pathway in lung epithelial cells |
| Q34325097 | Anti-CD137 antibodies in the treatment of autoimmune disease and cancer |
| Q34582700 | Antigen-independent signalosome of CARMA1, PKCθ, and TNF receptor-associated factor 2 (TRAF2) determines NF-κB signaling in T cells |
| Q35008690 | Arabidopsis thaliana BTB/ POZ-MATH proteins interact with members of the ERF/AP2 transcription factor family |
| Q36851678 | Assembling OX40 aptamers on a molecular scaffold to create a receptor-activating aptamer |
| Q35925874 | Assembly of post-receptor signaling complexes for the tumor necrosis factor receptor superfamily |
| Q48112970 | Augmentation of CD134 (OX40)-dependent NK anti-tumour activity is dependent on antibody cross-linking |
| Q36718807 | BK Virus Load Associated with Serum Levels of sCD30 in Renal Transplant Recipients |
| Q82542679 | Blockade of OX40-ligand after initial triggering of the T helper 2 response inhibits mercuric chloride-induced autoimmunity |
| Q59800859 | CD137 (4-1BB) Signalosome: Complexity Is a Matter of TRAFs |
| Q91737659 | CD137 Co-Stimulation Improves The Antitumor Effect Of LMP1-Specific Chimeric Antigen Receptor T Cells In Vitro And In Vivo |
| Q48340513 | CD137 Plays Both Pathogenic and Protective Roles in Type 1 Diabetes Development in NOD Mice |
| Q34582338 | CD137 signaling enhances tight junction resistance in intestinal epithelial cells |
| Q24647213 | CD28-independent, TRAF2-dependent costimulation of resting T cells by 4-1BB ligand |
| Q22253249 | Caspase-induced inactivation of the anti-apoptotic TRAF1 during Fas ligand-mediated apoptosis |
| Q42631651 | Characterization and expression analysis of TNFR-associated factor 1 (TRAF1) in grass carp Ctenopharyngodon idella |
| Q97424540 | Chimeric antigen receptor signaling: Functional consequences and design implications |
| Q28207052 | Co-stimulatory members of the TNFR family: keys to effective T-cell immunity? |
| Q39313794 | Comparative Analysis of Immune Checkpoint Molecules and Their Potential Role in the Transmissible Tasmanian Devil Facial Tumor Disease. |
| Q38919438 | Comparison of the peptide binding preferences of three closely related TRAF paralogs: TRAF2, TRAF3, and TRAF5 |
| Q33899607 | Control of immunity by the TNFR-related molecule OX40 (CD134) |
| Q33212786 | Costimulation by CD137/4-1BB inhibits T cell apoptosis and induces Bcl-xL and c-FLIP(short) via phosphatidylinositol 3-kinase and AKT/protein kinase B. |
| Q35145627 | Costimulation of T cells by OX40, 4-1BB, and CD27. |
| Q58741753 | Cryptic sequence features in the active postmortem transcriptome |
| Q47292379 | Crystal structure of murine 4-1BB and its interaction with 4-1BBL support a role for galectin-9 in 4-1BB signaling. |
| Q59980503 | Crystal structure of the m4-1BB/4-1BBL complex reveals an unusual dimeric ligand that undergoes structural changes upon 4-1BB receptor binding |
| Q38698632 | Deciphering CD137 (4-1BB) signaling in T-cell costimulation for translation into successful cancer immunotherapy |
| Q38498718 | Differential DNA methylation status between human preadipocytes and mature adipocytes |
| Q37657776 | Distinct functions of HTLV-1 Tax1 from HTLV-2 Tax2 contribute key roles to viral pathogenesis |
| Q43085782 | Effects of tumour necrosis factor-alpha on developing cerebellar granule and Purkinje neurons in vitro |
| Q48010492 | Enhanced immune-modulatory effects of thalidomide and dexamethasone co-treatment on T cell subsets. |
| Q78759402 | Expression and costimulatory effects of the TNF receptor superfamily members CD134 (OX40) and CD137 (4-1BB), and their role in the generation of anti-tumor immune responses |
| Q34095134 | Expression and function of TRAF-3 splice-variant isoforms in human lymphoma cell lines |
| Q54076273 | Expression of CD134 (0X-40) on T cells during the first 100 days following allogeneic bone marrow transplantation as a marker for lymphocyte activation and therapy-resistant graft-versus-host disease. |
| Q40560816 | Fc Engineering Approaches to Enhance the Agonism and Effector Functions of an Anti-OX40 Antibody. |
| Q36232655 | Function of tumor necrosis factor receptor family members on regulatory T-cells |
| Q35745563 | Gene expression profiling in an in vitro model of angiogenesis |
| Q38957340 | Genetic markers as therapeutic target in rheumatoid arthritis: A game changer in clinical therapy? |
| Q35718485 | Genome-wide expression profiling implicates a MAST3-regulated gene set in colonic mucosal inflammation of ulcerative colitis patients |
| Q38770814 | Harnessing co-stimulatory TNF receptors for cancer immunotherapy: Current approaches and future opportunities |
| Q92432857 | Immunization with mannosylated nanovaccines and inhibition of the immune-suppressing microenvironment sensitizes melanoma to immune checkpoint modulators |
| Q92710342 | Induction of NKG2D ligand expression on tumor cells by CD8+ T-cell engagement-mediated activation of nuclear factor-kappa B and p300/CBP-associated factor |
| Q34851737 | Intrinsic TNF/TNFR2 interactions fine-tune the CD8 T cell response to respiratory influenza virus infection in mice |
| Q24314418 | Isolation and characterization of two novel metalloproteinase genes linked to the Cdc2L locus on human chromosome 1p36.3 |
| Q35679587 | Loss of the signaling adaptor TRAF1 causes CD8+ T cell dysregulation during human and murine chronic infection |
| Q22254016 | MIP-T3, a novel protein linking tumor necrosis factor receptor-associated factor 3 to the microtubule network |
| Q94683589 | NF-κB in the New Era of Cancer Therapy |
| Q92453577 | NK cells for cancer immunotherapy |
| Q94552595 | New pathways in immune stimulation: targeting OX40 |
| Q48326988 | Novel CD137 Gene Polymorphisms and Susceptibility to Ischemic Stroke in the Northern Chinese Han Population. |
| Q39598751 | OX40 complexes with phosphoinositide 3-kinase and protein kinase B (PKB) to augment TCR-dependent PKB signaling |
| Q28188488 | OX40 promotes Bcl-xL and Bcl-2 expression and is essential for long-term survival of CD4 T cells |
| Q42227779 | Opposing roles for TRAF1 in the alternative versus classical NF-κB pathway in T cells |
| Q39939828 | Optimising anti-tumour CD8 T-cell responses using combinations of immunomodulatory antibodies. |
| Q41140315 | PKC-ѳ is dispensable for OX40L-induced TCR-independent Treg proliferation but contributes by enabling IL-2 production from effector T-cells |
| Q51973286 | Potent costimulation of human CD8 T cells by anti-4-1BB and anti-CD28 on synthetic artificial antigen presenting cells. |
| Q37368594 | Proteomic characterization of HIV-modulated membrane receptors, kinases and signaling proteins involved in novel angiogenic pathways. |
| Q34996759 | Reactive oxygen intermediates in TNF signaling |
| Q28137640 | Receptor activator of NF-kappaB recruits multiple TRAF family adaptors and activates c-Jun N-terminal kinase |
| Q40739297 | Recombinant glucocorticoid induced tumor necrosis factor receptor (rGITR) induces NOS in murine macrophage. |
| Q64990463 | Regulation of Interleukin-6 Receptor Signaling by TNF Receptor-Associated Factor 2 and 5 During Differentiation of Inflammatory CD4+ T Cells. |
| Q35990308 | Regulation of the PKCθ-NF-κB Axis in T Lymphocytes by the Tumor Necrosis Factor Receptor Family Member OX40 |
| Q38224322 | Regulatory tone and mucosal immunity in asthma |
| Q78028326 | Relative abilities of 4-1BB (CD137) and CD28 to co-stimulate the response of cytokine deflected Th1 and Th2 cells |
| Q58580426 | Role of TRAFs in Signaling Pathways Controlling T Follicular Helper Cell Differentiation and T Cell-Dependent Antibody Responses |
| Q48666974 | Role of Thalidomide on the Expression of OX40, 4-1BB, and GITR in T Cell Subsets |
| Q38179139 | Roles for TNF-receptor associated factor 3 (TRAF3) in lymphocyte functions |
| Q36380507 | Roles of OX40 in the pathogenesis and the control of diseases |
| Q26853280 | Roles of tumor necrosis factor receptor associated factor 3 (TRAF3) and TRAF5 in immune cell functions |
| Q36487245 | SA-4-1BBL as a novel adjuvant for the development of therapeutic cancer vaccines |
| Q35049033 | SUMOylation is required for optimal TRAF3 signaling capacity |
| Q40553282 | Secretions of MMP-9 by soluble glucocorticoid-induced tumor necrosis factor receptor (sGITR) mediated by protein kinase C (PKC)delta and phospholipase D (PLD) in murine macrophage |
| Q36370648 | Selective activation of the c-Jun NH2-terminal protein kinase signaling pathway by stimulatory KIR in the absence of KARAP/DAP12 in CD4+ T cells |
| Q24291496 | Sequence analysis identifies TTRAP, a protein that associates with CD40 and TNF receptor-associated factors, as a member of a superfamily of divalent cation-dependent phosphodiesterases |
| Q46036396 | Signaling through OX40 (CD134) breaks peripheral T-cell tolerance. |
| Q24539054 | Stress-induced decrease in TRAF2 stability is mediated by Siah2 |
| Q27617947 | Structural basis for self-association and receptor recognition of human TRAF2 |
| Q44818468 | Structural mapping of CD134 residues critical for interaction with feline immunodeficiency virus |
| Q57823195 | Synthetic immunology: T-cell engineering and adoptive immunotherapy |
| Q38086114 | T cell co-stimulatory molecules: a co-conspirator in the pathogenesis of eosinophilic esophagitis? |
| Q35021163 | T cell-NF-κB activation is required for tumor control in vivo |
| Q38168010 | T-cell costimulatory blockade in organ transplantation |
| Q37948129 | T-cell intrinsic effects of GITR and 4-1BB during viral infection and cancer immunotherapy |
| Q89467763 | THEMIS-SHP1 Recruitment by 4-1BB Tunes LCK-Mediated Priming of Chimeric Antigen Receptor-Redirected T Cells |
| Q30578474 | TNF receptor associated factors in cytokine signaling. |
| Q35534271 | TNF superfamily protein-protein interactions: feasibility of small- molecule modulation |
| Q37266849 | TNF superfamily: costimulation and clinical applications |
| Q40644972 | TNF-related weak inducer of apoptosis receptor, a TNF receptor superfamily member, activates NF-kappa B through TNF receptor-associated factors |
| Q38778362 | TNFR-Associated Factors 2 and 5 Differentially Regulate the Instructive IL-6 Receptor Signaling Required for Th17 Development. |
| Q40184385 | TNFSF9 exerts an inhibitory effect on hepatocellular carcinoma |
| Q28142929 | TRAF-3 interacts with p62 nucleoporin, a component of the nuclear pore central plug that binds classical NLS-containing import complexes |
| Q33876001 | TRAF-3 mRNA splice-deletion variants encode isoforms that induce NF-kappaB activation |
| Q37769438 | TRAF-mediated regulation of immune and inflammatory responses |
| Q28138885 | TRAF1 is a substrate of caspases activated during tumor necrosis factor receptor-alpha-induced apoptosis |
| Q50792035 | TRAF3 forms heterotrimers with TRAF2 and modulates its ability to mediate NF-{kappa}B activation. |
| Q28512952 | TROY, a newly identified member of the tumor necrosis factor receptor superfamily, exhibits a homology with Edar and is expressed in embryonic skin and hair follicles |
| Q38120535 | Targeting of the tumor necrosis factor receptor superfamily for cancer immunotherapy |
| Q81999267 | Targeting the CD134-CD134L interaction using anti-CD134 and/or rhCD134 fusion protein as a possible strategy to prevent lupus nephritis |
| Q53542645 | The 4-1BB ligand and 4-1BB expressed on osteoclast precursors enhance RANKL-induced osteoclastogenesis via bi-directional signaling. |
| Q40677513 | The Fn14 cytoplasmic tail binds tumour-necrosis-factor-receptor-associated factors 1, 2, 3 and 5 and mediates nuclear factor-kappaB activation |
| Q37062139 | The IKK-neutralizing compound Bay11 kills supereffector CD8 T cells by altering caspase-dependent activation-induced cell death |
| Q38073762 | The TNF receptor-ligands 4-1BB-4-1BBL and GITR-GITRL in NK cell responses |
| Q28198125 | The TNF-receptor-associated factor family: scaffold molecules for cytokine receptors, kinases and their regulators |
| Q33940420 | The adaptor TRAF5 limits the differentiation of inflammatory CD4(+) T cells by antagonizing signaling via the receptor for IL-6. |
| Q38541019 | The pharmacology of second-generation chimeric antigen receptors. |
| Q37524064 | The role of OX40-mediated co-stimulation in T-cell activation and survival |
| Q35145613 | The signaling adaptors and pathways activated by TNF superfamily |
| Q34979946 | The significance of OX40 and OX40L to T-cell biology and immune disease. |
| Q27619945 | The structural basis for the recognition of diverse receptor sequences by TRAF2 |
| Q36370712 | The transcriptional repressor Gfi1 affects development of early, uncommitted c-Kit+ T cell progenitors and CD4/CD8 lineage decision in the thymus |
| Q35192167 | Thermodynamic characterization of the interaction between TRAF2 and tumor necrosis factor receptor peptides by isothermal titration calorimetry |
| Q44503926 | Thyroid hormone induces the expression of 4-1BB and activation of caspases in a thyroid hormone receptor-dependent manner |
| Q88922346 | Toward Small-Molecule Inhibition of Protein-Protein Interactions: General Aspects and Recent Progress in Targeting Costimulatory and Coinhibitory (Immune Checkpoint) Interactions |
| Q39690697 | Triple expression of B7-1, B7-2 and 4-1BBL enhanced antitumor immune response against mouse H22 hepatocellular carcinoma |
| Q40321861 | Tumor necrosis factor receptor (TNFR)-associated factor 5 is a critical intermediate of costimulatory signaling pathways triggered by glucocorticoid-induced TNFR in T cells |
| Q34135071 | Tumor necrosis factor receptor-associated factor (TRAF) 2 and its role in TNF signaling. |
| Q28178466 | Tumor necrosis factor receptor-associated factor (TRAF) 4 is a new binding partner for the p70S6 serine/threonine kinase |
| Q28199382 | Tumor necrosis factor receptor-associated factors (TRAFs) |
Search more.